Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Teva Pharmaceutical Industries

Market Cap: CHF 18.6b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Novartis

Market Cap: CHF 180.1b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

Sandoz Group

Market Cap: CHF 21.8b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Johnson & Johnson

Market Cap: CHF 410.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Bayer

Market Cap: CHF 19.3b

Operates as a life science company worldwide.

Bristol-Myers Squibb

Market Cap: CHF 100.3b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Cosmo Pharmaceuticals

Market Cap: CHF 887.8m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Tilray Brands

Market Cap: CHF 678.0m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

AstraZeneca

Market Cap: CHF 169.8b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Merck

Market Cap: CHF 198.4b

Operates as a healthcare company worldwide.

Novartis

Market Cap: CHF 180.1b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

Newron Pharmaceuticals

Market Cap: CHF 143.5m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Jazz Pharmaceuticals

Market Cap: CHF 7.0b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

BioMarin Pharmaceutical

Market Cap: CHF 11.6b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Merck KGaA

Market Cap: CHF 45.9b

Operates as a science and technology company in Germany.

Gilead Sciences

Market Cap: CHF 94.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Qiagen

Market Cap: CHF 9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Roche Holding

Market Cap: CHF 213.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Gerresheimer

Market Cap: CHF 1.6b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Roche Holding

Market Cap: CHF 213.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Evotec

Market Cap: CHF 1.9b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Biogen

Market Cap: CHF 27.0b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Siegfried Holding

Market Cap: CHF 3.8b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Relief Therapeutics Holding

Market Cap: CHF 31.8m

A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally.

CRISPR Therapeutics

Market Cap: CHF 5.1b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Tecan Group

Market Cap: CHF 2.0b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

SKAN Group

Market Cap: CHF 1.5b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

BioNTech

Market Cap: CHF 26.8b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Amgen

Market Cap: CHF 145.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Siegfried Holding

Market Cap: CHF 3.9b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Moderna

Market Cap: CHF 53.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

UCB

Market Cap: CHF 16.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Basilea Pharmaceutica

Market Cap: CHF 660.0m

Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: US$22.4b

Joincare Pharmaceutical Group Industry Co.,Ltd.

Eli Lilly

Market Cap: CHF 670.0b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Santhera Pharmaceuticals Holding

Market Cap: CHF 173.8m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.